On July 2, IQVIA Holdings rose 6.11% in regular trading, trading at $204.55/share, with turnover of $161 million. The rally was primarily driven by Baird raising its price target on IQVIA from $230 to $249 on July 1, while maintaining its Outperform rating, implying approximately 21% upside from current levels.

According to FactSet data, the consensus analyst rating on IQVIA remains Buy with a mean price target of $224.17. The upgrade follows a period of mixed analyst sentiment — Morgan Stanley had downgraded the stock to Equal Weight in mid-June with a $200 target, while HSBC maintained Buy with a $210 target. Baird's latest move represents a notable shift in sentiment, reflecting growing confidence in the company's recovery trajectory.

Fundamentally, IQVIA reported Q1 adjusted EPS of $2.90, beating the $2.82 consensus by 2.84%, with revenue of $4.151 billion also exceeding estimates. The company maintained full-year revenue guidance of $17.15B-$17.35B. RBC Capital Markets has highlighted accelerating organic growth, AI tailwinds, and improving demand indicators as key positive catalysts for the stock.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)